Company Filing History:
Years Active: 2015
Title: The Innovations of Weiliang Weng in Traditional Chinese Medicine
Introduction: Weiliang Weng, located in Tianjin, China, is a notable inventor recognized for his contributions to the field of medicine through his innovative work with traditional Chinese herbal compositions. His expertise has led to the development of a specific patent focused on treating myocardial infarction, which highlights the integration of traditional medicine with modern medical practices.
Latest Patents: Weng holds a patent titled "Use of a Chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction." This invention relates to the preparation of a medicine that utilizes a specially formulated Chinese medicine composition. The formula consists of various herbal ingredients, including Radix Astragali (22.2%-66.8%), Radix Salviae Miltiorrhizae (11.6%-33.4%), Radix Notoginseng (2.5%-13.5%), and Lignum Dalbergiae Odoriferae (14.5%-44.3%). This patent signifies a critical advancement in using traditional medicine to enhance heart health.
Career Highlights: Weiliang Weng is associated with Tasly Pharmaceutical Group Co., Ltd., a prominent company in the pharmaceutical industry known for its commitment to integrating traditional Chinese medicine with modern treatments. His work at Tasly has greatly contributed to the company’s development of innovative health solutions.
Collaborations: Throughout his career, Weng has collaborated closely with colleagues such as Boli Zhang and Hongcai Shang. Their teamwork reflects a strong commitment to research and development in the field of medicine, fostering innovations that can benefit patients worldwide.
Conclusion: Weiliang Weng’s innovative work, particularly in the realm of traditional Chinese medicine, exemplifies how historical practices can be blended with contemporary medical needs. His patent represents a significant step toward enhancing patient care in the prevention of myocardial infarction. The ongoing efforts of inventors like Weng in collaboration with institutions like Tasly Pharmaceutical Group Co., Ltd. highlight the potential of traditional medicine in modern healthcare solutions.